115 related articles for article (PubMed ID: 10556819)
41. Protective effects of overexpression TCR Vbeta5.2-HSP70 and TCR Vbeta8.2-HSP70 against collagen-induced arthritis in rats.
Xiao J; Li S; Wang W; Li Y; Zhao W
Cell Mol Immunol; 2007 Dec; 4(6):439-45. PubMed ID: 18163955
[TBL] [Abstract][Full Text] [Related]
42. Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis.
Myers LK; Stuart JM; Seyer JM; Kang AH
J Exp Med; 1989 Dec; 170(6):1999-2010. PubMed ID: 2479704
[TBL] [Abstract][Full Text] [Related]
43. Vaccination with a recombinant V alpha domain of a TCR prevents the development of collagen-induced arthritis.
Rosloniec EF; Brand DD; Whittington KB; Stuart JM; Ciubotaru M; Ward ES
J Immunol; 1995 Nov; 155(9):4504-11. PubMed ID: 7594614
[TBL] [Abstract][Full Text] [Related]
44. Emergence of a type II collagen-specific helper T cell response.
Pogue-Caley RR; McHeyzer-Williams MG
Eur J Immunol; 2001 Aug; 31(8):2362-72. PubMed ID: 11500819
[TBL] [Abstract][Full Text] [Related]
45. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
[TBL] [Abstract][Full Text] [Related]
46. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
47. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
48. Arthritis susceptibility in mice expressing human type II collagen in cartilage.
Malmström V; Ho KK; Lun J; Tam PP; Cheah KS; Holmdahl R
Scand J Immunol; 1997 Jun; 45(6):670-7. PubMed ID: 9201307
[TBL] [Abstract][Full Text] [Related]
49. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice.
Taylor PC; Plater-Zyberk C; Maini RN
Eur J Immunol; 1995 Mar; 25(3):763-9. PubMed ID: 7705406
[TBL] [Abstract][Full Text] [Related]
50. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
[TBL] [Abstract][Full Text] [Related]
51. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
[TBL] [Abstract][Full Text] [Related]
52. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
53. T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis.
Malmström V; Bäcklund J; Jansson L; Kihlberg J; Holmdahl R
Arthritis Res; 2000; 2(4):315-26. PubMed ID: 11056672
[TBL] [Abstract][Full Text] [Related]
54. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis.
Rosloniec EF; Whittington KB; Brand DD; Myers LK; Stuart JM
Cell Immunol; 1996 Aug; 172(1):21-8. PubMed ID: 8806802
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
56. Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis.
Yuasa T; Kubo S; Yoshino T; Ujike A; Matsumura K; Ono M; Ravetch JV; Takai T
J Exp Med; 1999 Jan; 189(1):187-94. PubMed ID: 9874575
[TBL] [Abstract][Full Text] [Related]
57. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells.
Yamada H; Dzhambazov B; Bockermann R; Blom T; Holmdahl R
J Immunol; 2004 Oct; 173(7):4729-35. PubMed ID: 15383610
[TBL] [Abstract][Full Text] [Related]
58. T cell regulation of collagen-induced arthritis in mice. I. Isolation of Type II collagen-reactive T cell hybridomas with specific cytotoxic function.
Chiocchia G; Boissier MC; Ronziere MC; Herbage D; Fournier C
J Immunol; 1990 Jul; 145(2):519-25. PubMed ID: 2114442
[TBL] [Abstract][Full Text] [Related]
59. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Gonzalo-Gil E; Pérez-Lorenzo MJ; Galindo M; Díaz de la Guardia R; López-Millán B; Bueno C; Menéndez P; Pablos JL; Criado G
Arthritis Res Ther; 2016 Apr; 18():77. PubMed ID: 27036118
[TBL] [Abstract][Full Text] [Related]
60. Exacerbation of collagen-induced arthritis in rats by rat cytomegalovirus is antigen-specific.
Griffiths MM; Sawitzke AD; Harper DS; McCall S; Reese VR; Cannon GW
Autoimmunity; 1994; 18(3):177-87. PubMed ID: 7858103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
